Cargando…

Feasibility of a Randomized Controlled Trial of Paediatric Interdisciplinary Pain Management Using Home-Based Telehealth

PURPOSE: Chronic pain is common in adolescents. Evidence-based guidelines recommend interdisciplinary treatment, but access is limited by geography. The development of hybrid programs utilizing both face-to-face and videoconference treatment may help overcome this. We developed a 7-week hybrid pedia...

Descripción completa

Detalles Bibliográficos
Autores principales: Hilyard, Anna, Kingsley, Julia, Sommerfield, David, Taylor, Susan, Bear, Natasha, Gibson, Noula
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7200248/
https://www.ncbi.nlm.nih.gov/pubmed/32431538
http://dx.doi.org/10.2147/JPR.S217022
_version_ 1783529299130712064
author Hilyard, Anna
Kingsley, Julia
Sommerfield, David
Taylor, Susan
Bear, Natasha
Gibson, Noula
author_facet Hilyard, Anna
Kingsley, Julia
Sommerfield, David
Taylor, Susan
Bear, Natasha
Gibson, Noula
author_sort Hilyard, Anna
collection PubMed
description PURPOSE: Chronic pain is common in adolescents. Evidence-based guidelines recommend interdisciplinary treatment, but access is limited by geography. The development of hybrid programs utilizing both face-to-face and videoconference treatment may help overcome this. We developed a 7-week hybrid pediatric interdisciplinary pain program (Hybrid-PIPP) and wished to compare it to individual face-to-face sessions (Standard Care). Our objective was to test the feasibility of a protocol that used a matched pair un-blinded randomized controlled design to investigate the efficacy and cost-effectiveness of the Hybrid-PIPP compared to Standard Care. PATIENTS AND METHODS: Parent–adolescent dyads were recruited from tertiary pediatric clinics and matched by disability before randomization to minimize allocation bias. The adolescents (aged 11–17) had experienced primary pain for >3 months. Hybrid-PIPP involved 11 hrs of group therapy and 4 individual videoconference sessions. Standard care was provided by the same clinical team, using the same treatment model and similar intensity as the Hybrid-PIPP. The intention was to recruit participants for 3 Hybrid-PIPP groups with a comparison stream. Recruitment was ceased after 2 groups due to the high participant disability requiring more intensive intervention. RESULTS: Eighteen dyads were screened and 13 randomized (7 Hybrid-PIPP, 6 Standard Care, 2 unsuitable, 3 unallocated when the study was stopped). The study met a priori feasibility criteria for staff availability; recruitment rate; treatment completion; and data collection. Global satisfaction ratings were similar in both streams (SC median 7, range 5–9 and Hybrid-PIPP median 8.5, range 5–10). Challenges were identified in both streams. A future modified Hybrid-PIPP was considered acceptable if the intensity is increased to manage the high level of disability. Standard care was considered inefficient. No adverse events were reported. CONCLUSION: The study determined that the protocol met a priori feasibility criteria, but to be practicable in a real world, health environment requires significant modifications. REGISTRATION: ANZTR(ACTRN2614000489695).
format Online
Article
Text
id pubmed-7200248
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-72002482020-05-19 Feasibility of a Randomized Controlled Trial of Paediatric Interdisciplinary Pain Management Using Home-Based Telehealth Hilyard, Anna Kingsley, Julia Sommerfield, David Taylor, Susan Bear, Natasha Gibson, Noula J Pain Res Original Research PURPOSE: Chronic pain is common in adolescents. Evidence-based guidelines recommend interdisciplinary treatment, but access is limited by geography. The development of hybrid programs utilizing both face-to-face and videoconference treatment may help overcome this. We developed a 7-week hybrid pediatric interdisciplinary pain program (Hybrid-PIPP) and wished to compare it to individual face-to-face sessions (Standard Care). Our objective was to test the feasibility of a protocol that used a matched pair un-blinded randomized controlled design to investigate the efficacy and cost-effectiveness of the Hybrid-PIPP compared to Standard Care. PATIENTS AND METHODS: Parent–adolescent dyads were recruited from tertiary pediatric clinics and matched by disability before randomization to minimize allocation bias. The adolescents (aged 11–17) had experienced primary pain for >3 months. Hybrid-PIPP involved 11 hrs of group therapy and 4 individual videoconference sessions. Standard care was provided by the same clinical team, using the same treatment model and similar intensity as the Hybrid-PIPP. The intention was to recruit participants for 3 Hybrid-PIPP groups with a comparison stream. Recruitment was ceased after 2 groups due to the high participant disability requiring more intensive intervention. RESULTS: Eighteen dyads were screened and 13 randomized (7 Hybrid-PIPP, 6 Standard Care, 2 unsuitable, 3 unallocated when the study was stopped). The study met a priori feasibility criteria for staff availability; recruitment rate; treatment completion; and data collection. Global satisfaction ratings were similar in both streams (SC median 7, range 5–9 and Hybrid-PIPP median 8.5, range 5–10). Challenges were identified in both streams. A future modified Hybrid-PIPP was considered acceptable if the intensity is increased to manage the high level of disability. Standard care was considered inefficient. No adverse events were reported. CONCLUSION: The study determined that the protocol met a priori feasibility criteria, but to be practicable in a real world, health environment requires significant modifications. REGISTRATION: ANZTR(ACTRN2614000489695). Dove 2020-05-01 /pmc/articles/PMC7200248/ /pubmed/32431538 http://dx.doi.org/10.2147/JPR.S217022 Text en © 2020 Hilyard et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Hilyard, Anna
Kingsley, Julia
Sommerfield, David
Taylor, Susan
Bear, Natasha
Gibson, Noula
Feasibility of a Randomized Controlled Trial of Paediatric Interdisciplinary Pain Management Using Home-Based Telehealth
title Feasibility of a Randomized Controlled Trial of Paediatric Interdisciplinary Pain Management Using Home-Based Telehealth
title_full Feasibility of a Randomized Controlled Trial of Paediatric Interdisciplinary Pain Management Using Home-Based Telehealth
title_fullStr Feasibility of a Randomized Controlled Trial of Paediatric Interdisciplinary Pain Management Using Home-Based Telehealth
title_full_unstemmed Feasibility of a Randomized Controlled Trial of Paediatric Interdisciplinary Pain Management Using Home-Based Telehealth
title_short Feasibility of a Randomized Controlled Trial of Paediatric Interdisciplinary Pain Management Using Home-Based Telehealth
title_sort feasibility of a randomized controlled trial of paediatric interdisciplinary pain management using home-based telehealth
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7200248/
https://www.ncbi.nlm.nih.gov/pubmed/32431538
http://dx.doi.org/10.2147/JPR.S217022
work_keys_str_mv AT hilyardanna feasibilityofarandomizedcontrolledtrialofpaediatricinterdisciplinarypainmanagementusinghomebasedtelehealth
AT kingsleyjulia feasibilityofarandomizedcontrolledtrialofpaediatricinterdisciplinarypainmanagementusinghomebasedtelehealth
AT sommerfielddavid feasibilityofarandomizedcontrolledtrialofpaediatricinterdisciplinarypainmanagementusinghomebasedtelehealth
AT taylorsusan feasibilityofarandomizedcontrolledtrialofpaediatricinterdisciplinarypainmanagementusinghomebasedtelehealth
AT bearnatasha feasibilityofarandomizedcontrolledtrialofpaediatricinterdisciplinarypainmanagementusinghomebasedtelehealth
AT gibsonnoula feasibilityofarandomizedcontrolledtrialofpaediatricinterdisciplinarypainmanagementusinghomebasedtelehealth